WW International announced Friday that CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a ...

People with type 2 diabetes and obesity who develop kidney disease may benefit more from bariatric surgery than from GLP-1 ...

BOSTON - There is concern over the newest weight loss drugs sparking eating disorders in teens. Newer GLP-1 weight loss drugs ...

Jon Gosselin dropped more than 50 lbs after starting semaglutide injections, but once he ran out of the weight-loss shots due ...

If you're looking to lose weight, the Zone Diet, created by Dr. Barry Sears, may be worth checking out. A dietitian shares ...

The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...

The simplicity of intermittent fasting might make it more appealing and easier to maintain than other weight-loss plans, ...

The safety of a calorie deficit for weight loss depends on things like your starting weight, overall health and unique ...

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

The arrival of GLP-1 analog drugs (such as Wegovy) marked a huge shift in the weight-loss drug market. These drugs have been ...

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.